Does Semaglutide Improve Outcomes for Obese Patients With HS?
Semaglutide (Ozempic, Wegovy, Novo Nordisk) injections may reduce flares and boost quality of life among obese people with hidradenitis suppurativa (HS) when added to standard HS therapies, according to research presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024 in Amsterdam. The study, which examined data from June 2020 to March 2023, […]